{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T16:06:08Z","timestamp":1746201968951},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.exer.2007.10.003","type":"journal-article","created":{"date-parts":[[2007,11,26]],"date-time":"2007-11-26T12:14:19Z","timestamp":1196079259000},"page":"131-137","source":"Crossref","is-referenced-by-count":12,"title":["Rifampicin inhibits the retinal neovascularization in vitro and in vivo"],"prefix":"10.1016","volume":"86","author":[{"given":"Yuichi","family":"Chikaraishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nozomu","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masamitsu","family":"Shimazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2007.10.003_bib1","series-title":"Proceedings of the 6th International Congress of Chemotherapy","first-page":"755","article-title":"Absorption and elimination of the antibiotic rifampicin in newborns and children","author":"Acocella","year":"1969"},{"key":"10.1016\/j.exer.2007.10.003_bib2","first-page":"350","article-title":"Cell proliferation and nucleic acid synthesis in cells treated with rifampin","volume":"22","author":"Adhvaryu","year":"1984","journal-title":"Indian J. Exp. Biol."},{"key":"10.1016\/j.exer.2007.10.003_bib3","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJMoa062655","article-title":"Ranibizumab versus verteporfin for neovascular age-related macular degeneration","volume":"355","author":"Brown","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.exer.2007.10.003_bib4","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.exer.2006.11.007","article-title":"New quantitative analysis, using high-resolution images, of oxygen-induced retinal neovascularization in mice","volume":"84","author":"Chikaraishi","year":"2007","journal-title":"Exp. Eye. Res."},{"key":"10.1016\/j.exer.2007.10.003_bib5","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0891-5849(98)00115-4","article-title":"Upregulation of vascular endothelial growth factor by H2O2 in rat heart endothelial cells","volume":"25","author":"Chua","year":"1998","journal-title":"Free. Radic. Biol. Med."},{"key":"10.1016\/j.exer.2007.10.003_bib6","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1056\/NEJMoa042760","article-title":"Pegaptanib for neovascular age-related macular degeneration","volume":"351","author":"Gragoudas","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.exer.2007.10.003_bib7","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1046\/j.1442-9071.2003.00683.x","article-title":"New treatments in age-related macular degeneration","volume":"31","author":"Hooper","year":"2003","journal-title":"Clin. Experiment. Ophthalmol."},{"key":"10.1016\/j.exer.2007.10.003_bib8","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0736-0266(01)00022-5","article-title":"Toxic effect of rifampicin on human osteoblast-like cells","volume":"19","author":"Isefuku","year":"2001","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.exer.2007.10.003_bib9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00401-004-0867-6","article-title":"Rifampicin inhibits neurodegeneration in the optic nerve transection model in vivo and after 1-methyl-4-phenylpyridinium intoxication in vitro","volume":"108","author":"Kilic","year":"2004","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"10.1016\/j.exer.2007.10.003_bib10","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1172\/JCI1277","article-title":"Advanced glycation end products increase retinal vascular endothelial growth factor expression","volume":"101","author":"Lu","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.exer.2007.10.003_bib11","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/00006324-199302000-00010","article-title":"Role of lasers in eye care","volume":"70","author":"Lyle","year":"1993","journal-title":"Optom. Vis. Sci."},{"key":"10.1016\/j.exer.2007.10.003_bib12","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3109\/08820539909069538","article-title":"Decreasing retinal photocoagulation damage: principles and techniques","volume":"14","author":"Mainster","year":"1999","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.exer.2007.10.003_bib13","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/jac\/31.5.731","article-title":"Penetration of rifampicin into the brain tissue and cerebral extracellular space of rats","volume":"31","author":"Mindermann","year":"1993","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.exer.2007.10.003_bib14","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1128\/AAC.42.10.2626","article-title":"Rifampin concentrations in various compartments of the human brain: a novel method for determining drug levels in the cerebral extracellular space","volume":"42","author":"Mindermann","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exer.2007.10.003_bib15","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.brainres.2006.01.116","article-title":"Rifampicin attenuates the MPTP-induced neurotoxicity in mouse brain","volume":"1082","author":"Oida","year":"2006","journal-title":"Brain. Res."},{"key":"10.1016\/j.exer.2007.10.003_bib16","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0891-5849(96)00479-0","article-title":"Effect of a water-soluble vitamin E analog, trolox C, on retinal vascular development in an animal model of retinopathy of prematurity","volume":"22","author":"Penn","year":"1997","journal-title":"Free. Radic. Biol. Med."},{"key":"10.1016\/j.exer.2007.10.003_bib17","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1006\/cyto.1999.0566","article-title":"Vascular endothelial growth factor (VEGF) and melanoma. N-acetylcysteine downregulates VEGF production in vitro","volume":"12","author":"Redondo","year":"2000","journal-title":"Cytokine"},{"key":"10.1016\/j.exer.2007.10.003_bib18","series-title":"The Extra Pharmacopoeia","author":"Reynolds","year":"1993"},{"key":"10.1016\/j.exer.2007.10.003_bib19","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2165\/00128072-200103040-00003","article-title":"The management of retinopathy of prematurity","volume":"3","author":"Reynolds","year":"2001","journal-title":"Paediatr. Drugs"},{"key":"10.1016\/j.exer.2007.10.003_bib20","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.cardiores.2004.08.006","article-title":"Vitamins C and E prevent endothelial VEGF and VEGFR-2 overexpression induced by porcine hypercholesterolemic LDL","volume":"65","author":"Rodriguez","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.exer.2007.10.003_bib21","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.exer.2007.10.003_bib22","first-page":"101","article-title":"Oxygen-induced retinopathy in the mouse","volume":"35","author":"Smith","year":"1994","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2007.10.003_bib23","series-title":"RNA Polymerase and Transcription. Proceedings of the Lepetit Colloquium","first-page":"260","article-title":"The effect of rifampicin on mammalian viruses and cells","author":"Subak-Sharpe","year":"1970"},{"issue":"Suppl. 3","key":"10.1016\/j.exer.2007.10.003_bib24","doi-asserted-by":"crossref","first-page":"S412","DOI":"10.1093\/clinids\/5.Supplement_3.S412","article-title":"Rifampin: spectrum of antibacterial activity","volume":"5","author":"Thornsberry","year":"1983","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.exer.2007.10.003_bib25","doi-asserted-by":"crossref","first-page":"6839","DOI":"10.1074\/jbc.271.12.6839","article-title":"Inhibition of amyloid beta protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxyl radical scavenger","volume":"271","author":"Tomiyama","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exer.2007.10.003_bib26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/10715769709097783","article-title":"Prevention of peroxynitrite-dependent tyrosine nitration and inactivation of alpha1-antiproteinase by antibiotics","volume":"26","author":"Whiteman","year":"1997","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.exer.2007.10.003_bib27","doi-asserted-by":"crossref","first-page":"5096","DOI":"10.1074\/jbc.275.7.5096","article-title":"Utilization of distinct signaling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation","volume":"275","author":"Wu","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exer.2007.10.003_bib28","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.brainres.2003.10.012","article-title":"Rifampicin attenuates brain damage in focal ischemia","volume":"996","author":"Yulug","year":"2004","journal-title":"Brain. Res."},{"key":"10.1016\/j.exer.2007.10.003_bib29","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1179\/joc.2004.16.4.357","article-title":"Immunomodulating activity of rifampicin","volume":"16","author":"Ziglam","year":"2004","journal-title":"J. Chemother."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483507002965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483507002965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,4]],"date-time":"2019-05-04T23:42:43Z","timestamp":1557013363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483507002965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0014483507002965"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2007.10.003","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}